- Home
- MFH vs STIM Comparison
MFH vs STIM Comparison
Compare MFH & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MFH
- STIM
- Stock Information
- Founded
- MFH 2011
- STIM 2003
- Country
- MFH United States
- STIM United States
- Employees
- MFH N/A
- STIM N/A
- Industry
- MFH Finance: Consumer Services
- STIM Medical/Dental Instruments
- Sector
- MFH Finance
- STIM Health Care
- Exchange
- MFH Nasdaq
- STIM Nasdaq
- Market Cap
- MFH 247.1M
- STIM 232.3M
- IPO Year
- MFH N/A
- STIM 2018
- Fundamental
- Price
- MFH $4.09
- STIM $3.34
- Analyst Decision
- MFH
- STIM Buy
- Analyst Count
- MFH 0
- STIM 4
- Target Price
- MFH N/A
- STIM $6.00
- AVG Volume (30 Days)
- MFH 541.1K
- STIM 884.9K
- Earning Date
- MFH 07-15-2025
- STIM 08-11-2025
- Dividend Yield
- MFH N/A
- STIM N/A
- EPS Growth
- MFH N/A
- STIM N/A
- EPS
- MFH N/A
- STIM N/A
- Revenue
- MFH N/A
- STIM $89,448,000.00
- Revenue This Year
- MFH N/A
- STIM $104.65
- Revenue Next Year
- MFH N/A
- STIM $10.69
- P/E Ratio
- MFH N/A
- STIM N/A
- Revenue Growth
- MFH 125.92
- STIM 22.16
- 52 Week Low
- MFH $1.03
- STIM $0.52
- 52 Week High
- MFH $8.86
- STIM $5.92
- Technical
- Relative Strength Index (RSI)
- MFH 52.50
- STIM 36.21
- Support Level
- MFH $3.80
- STIM $3.11
- Resistance Level
- MFH $4.41
- STIM $3.61
- Average True Range (ATR)
- MFH 0.39
- STIM 0.20
- MACD
- MFH 0.12
- STIM 0.01
- Stochastic Oscillator
- MFH 90.35
- STIM 36.76
About MFH Mercurity Fintech Holding Inc.
Mercurity Fintech Holding Inc is a New York-based digital fintech leader providing access to the rapidly growing AI-powered infrastructure, blockchain, and digital assets sectors. Its three core business lines include: 1. Blockchain and digital asset solutions. 2. AI and HPC infrastructure, specializing in developing liquid cooling solutions for AI data centers. 3. Comprehensive financial services.
About STIM Neuronetics Inc.
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.